Voya Financial Advisors Inc. Sells 164 Shares of Colgate-Palmolive (NYSE:CL)

Voya Financial Advisors Inc. reduced its stake in shares of Colgate-Palmolive (NYSE:CL) by 1.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,392 shares of the company’s stock after selling 164 shares during the quarter. Voya Financial Advisors Inc.’s holdings in Colgate-Palmolive were worth $711,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank purchased a new stake in Colgate-Palmolive in the fourth quarter valued at about $742,997,000. American International Group Inc. increased its holdings in shares of Colgate-Palmolive by 390.4% in the fourth quarter. American International Group Inc. now owns 2,252,792 shares of the company’s stock valued at $192,636,000 after purchasing an additional 1,793,428 shares during the period. Morgan Stanley increased its holdings in shares of Colgate-Palmolive by 22.9% in the fourth quarter. Morgan Stanley now owns 4,309,285 shares of the company’s stock valued at $368,488,000 after purchasing an additional 801,541 shares during the period. UBS Asset Management Americas Inc. increased its holdings in shares of Colgate-Palmolive by 12.5% in the fourth quarter. UBS Asset Management Americas Inc. now owns 4,545,448 shares of the company’s stock valued at $388,681,000 after purchasing an additional 505,307 shares during the period. Finally, Lazard Freres Gestion S.A.S. acquired a new position in shares of Colgate-Palmolive in the fourth quarter valued at about $36,873,000. Hedge funds and other institutional investors own 76.47% of the company’s stock.

A number of research analysts have recently weighed in on CL shares. Stifel Nicolaus lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $83.00 price objective on the stock. in a report on Thursday, January 28th. Royal Bank of Canada lowered Colgate-Palmolive from an “outperform” rating to a “sector perform” rating and set a $90.00 price objective on the stock. in a report on Monday, January 4th. Berenberg Bank raised Colgate-Palmolive from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a report on Tuesday, January 26th. Sanford C. Bernstein assumed coverage on Colgate-Palmolive in a report on Tuesday, January 19th. They set an “underperform” rating and a $77.00 target price on the stock. Finally, Credit Suisse Group raised Colgate-Palmolive from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $70.00 to $80.00 in a report on Monday, February 1st. Two analysts have rated the stock with a sell rating, six have given a hold rating and two have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $81.91.

In other news, insider John W. Kooyman sold 463 shares of the firm’s stock in a transaction that occurred on Tuesday, February 16th. The stock was sold at an average price of $77.16, for a total value of $35,725.08. Following the transaction, the insider now owns 7,160 shares in the company, valued at $552,465.60. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Philip G. Shotts sold 346 shares of the firm’s stock in a transaction that occurred on Tuesday, February 16th. The shares were sold at an average price of $77.16, for a total value of $26,697.36. Following the completion of the transaction, the vice president now owns 41,128 shares in the company, valued at approximately $3,173,436.48. The disclosure for this sale can be found here. Over the last three months, insiders sold 30,810 shares of company stock worth $2,418,650. 0.78% of the stock is owned by corporate insiders.

Shares of CL opened at $79.62 on Thursday. The company has a current ratio of 0.97, a quick ratio of 0.62 and a debt-to-equity ratio of 6.50. Colgate-Palmolive has a 12 month low of $65.54 and a 12 month high of $86.41. The stock’s 50 day moving average is $76.89 and its two-hundred day moving average is $80.38. The firm has a market cap of $67.48 billion, a P/E ratio of 25.44, a PEG ratio of 3.83 and a beta of 0.59.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Thursday, January 28th. The company reported $0.77 EPS for the quarter, beating the consensus estimate of $0.76 by $0.01. Colgate-Palmolive had a return on equity of 383.88% and a net margin of 16.65%. The company had revenue of $4.32 billion for the quarter, compared to analyst estimates of $4.15 billion. During the same period last year, the company earned $0.73 earnings per share. Colgate-Palmolive’s quarterly revenue was up 7.7% compared to the same quarter last year. Equities research analysts forecast that Colgate-Palmolive will post 3.05 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 14th. Shareholders of record on Wednesday, April 21st will be issued a $0.45 dividend. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a yield of 2.26%. The ex-dividend date of this dividend is Tuesday, April 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 62.19%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment's products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.

Featured Story: Special Purpose Acquisition Company (SPAC)

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.